Alkermes
在场
是其中之一......
Alkermes 是一家在股票代码 ALKS (US) 下上市的公司。
Alkermes 在 2 个国家有直接业务。
他们在：
高管
查看带有其 59 名主要高管的组织结构图
Alkermes 搜索最多的简介
- Richard Pops, Chairman of the Board and Chief Executive Officer
- Nancy Snyderman, Director
- Brian McKeon, Director
高管在Alkermes变化
- Nancy Lurker已作为Director加入公司 (新闻发布的2024三月8号).
- Nancy Wysenski, Lead Director, 已经离开公司 (新闻发布的2023十二月11号).
创建提醒
跟踪 Alkermes 的高管变动
生物技术
Alkermes 拥有 2,275 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Histogen has filed for bankruptcy protection (公布2024四月19号).
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (公布2024四月16号).
生物技术 行业的其他推荐联系人
消息
Alkermes 的最新新闻稿
- Alkermes plc Reports Second Quarter 2022 Financial Results | Alkermes plc
- Alkermes to Report Second Quarter Financial Results on July 27, 2022 | Alkermes plc
- Alkermes Announces Results of Annual General Meeting of Shareholders | Alkermes plc
- Alkermes to Participate in the Goldman Sachs Healthcare Conference | Alkermes plc
- Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer | Alkermes plc
- Alkermes to Participate in the Jefferies Healthcare Conference | Alkermes plc
- Alkermes Presents ARTISTRY-1 Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | Alkermes plc
- Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors | Alkermes plc
- Alkermes Announces Four Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | Alkermes plc
- Our Stories
- View more press releases Close
通过电子邮件
